United Microelectronics ADR

Cutting-Edge Cardiac Research: Novoheart's CTScreen™ system has been installed at UMC Utrecht, equipping Regenerative Medicine Center with advanced high-throughput tools to accelerate human cardiac disease modeling and therapeutic screening, including both drug candidates and gene editing approaches Driving Innovation: This installation paves the way for future co-development projects with UMC Utrecht, advancing human-based research and cardiac regenerative technologies BOSTON and UTRECHT, Netherlands, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat or currently incurable diseases with significant unmet needs, and Novoheart, its wholly owned pre-clinical subsidiary pioneering human-based cardiac tissue engineering for disease modelling and drug screening, are pleased to announce the installation of their state-of-the-art CTScreen™ platform at the University Medical Center Utrecht (UMC Utrecht). This milestone equips the Regenerative Medicine Center Utrecht with a leading-edge system to model human cardiac diseases, develop therapies, and transform preclinical cardiac research.» Mehr auf globenewswire.com

TAIPEI, Taiwan--(BUSINESS WIRE)--United Microelectronics Corporation (NYSE: UMC; TWSE: 2303) (“UMC”), today reported unaudited net sales for the month of January 2025. Revenues for January 2025 Period 2025 2024 Y/Y Change Y/Y (%) January 19,806,795 19,013,697 793,098 4.17% Jan.-Jan. 19,806,795 19,013,697 793,098 4.17% (*) All figures in thousands of New Taiwan Dollars (NT$), except for percentages (**) All figures are consolidated Additional information about UMC is available on the web at http.» Mehr auf businesswire.com

United Microelectronics stock fell 5% after Citibank downgraded it from buy to sell, citing gross margin weakness and competitive pressures. The company reported lower-than-expected earnings for Q4, driven by lower gross margins and non-operating income expenses. Despite challenges, UMC maintains a strong cash position and plans to continue a strong dividend policy.» Mehr auf seekingalpha.com